Response to lamivudine therapy in children chronically infected with hepatitis B virus (HBV)

被引：0
|
作者：
Hagmann, S [1 ]
Chung, M [1 ]
Rochford, G [1 ]
Jani, M [1 ]
Sitnitskaya, Y [1 ]
Pollack, H [1 ]
机构：
[1] NYU, Sch Med, New York, NY USA
来源：
CLINICAL INFECTIOUS DISEASES | 2001年 / 33卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
427
引用
收藏
页码：1161 / 1161
页数：1
相关论文
共 50 条
  • [21] Prevalence of hepatitis B virus precore stop codon mutations in chronically infected children
    Philip Wintermeyer
    Patrick Gerner
    Stephan Gehring
    Afshin Karimi
    Stefan Wirth
    World Journal of Gastroenterology, 2006, (14) : 2235 - 2238
  • [22] Lamivudine for nephrotic syndrome related to hepatitis B virus (HBV) infection
    Kanaan, N
    Horsmans, Y
    Goffin, E
    CLINICAL NEPHROLOGY, 2006, 65 (03) : 208 - 210
  • [23] Characterisation and clinical significance of lamivudine resistant hepatitis B virus (HBV) mutations in human immunodeficiency virus (HIV) and HBV co-infected individuals
    Bartholomeusz, A
    Locarnini, S
    Ayres, A
    Cooley, L
    Lewin, S
    Crowe, S
    Mijch, A
    Roberts, S
    Sasadeusz, J
    ANTIVIRAL RESEARCH, 2003, 57 (03) : A43 - A43
  • [24] Effect of long-term lamivudine in chronic hepatitis B virus-infected children
    Ozgenç, F
    Arikan, C
    Sertoz, RY
    Nart, D
    Aydogdu, S
    Yagci, RV
    ANTIVIRAL THERAPY, 2004, 9 (05) : 729 - 732
  • [25] Predictive value of hepatitis B virus cccDNA in PBMC of response to lamivudine therapy in patients with chronic hepatitis B
    Guo, Hao-Yu
    Tan, De-Ming
    Xu, Xu-Wen
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 : A117 - A118
  • [26] Low rate of YMDD motif mutations in polymerase gene of hepatitis B virus in chronically infected patients not treated with lamivudine
    Matsuda, M
    Suzuki, F
    Suzuki, Y
    Tsubota, A
    Akuta, N
    Hosaka, T
    Someya, T
    Kobayashi, M
    Saitoh, S
    Arase, Y
    Satoh, J
    Takagi, K
    Kobayashi, M
    Ikeda, K
    Kumada, H
    JOURNAL OF GASTROENTEROLOGY, 2004, 39 (01) : 34 - 40
  • [27] Monitoring drug resistance in chronic hepatitis B virus (HBV)-infected patients during lamivudine therapy: Evaluation of performance of INNO-LiPA HBV DR assay
    Lok, ASF
    Zoulim, F
    Locarnini, S
    Mangia, A
    Niro, G
    Decraemer, H
    Maertens, G
    Hulstaert, F
    De Vreese, K
    Sablon, E
    JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (10) : 3729 - 3734
  • [28] Low rate of YMDD motif mutations in polymerase gene of hepatitis B virus in chronically infected patients not treated with lamivudine
    Marie Matsuda
    Fumitaka Suzuki
    Yoshiyuki Suzuki
    Akihito Tsubota
    Norio Akuta
    Tetsuya Hosaka
    Takashi Someya
    Masahiro Kobayashi
    Satoshi Saitoh
    Yasuji Arase
    Junko Satoh
    Kimiko Takagi
    Mariko Kobayashi
    Kenji Ikeda
    Hiromitsu Kumada
    Journal of Gastroenterology, 2004, 39 : 34 - 40
  • [29] Lamivudine may prevent HBV reactivation during immunosuppressive therapy - Lamivudine therapy for prevention of immunosuppressive-induced hepatitis B virus reactivation in hepatitis B surface antigen carriers
    Shibolet, O
    Ilan, Y
    Gillis, S
    INFECTIONS IN MEDICINE, 2002, 19 (11) : 536 - 536
  • [30] Characterization of hepatitis B virus genotypes in chronically infected patients
    Basaras, M.
    Arrese, E.
    Blanco, S.
    Sota, M.
    de las Heras, B.
    Cisterna, R.
    REVISTA ESPANOLA DE QUIMIOTERAPIA, 2007, 20 (04) : 442 - 445
12345